## ASML: ASML Holding N.V. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -2.1% below STRENGTH zone (4.0-10.0%); PEG 2.01 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (25% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1013.49)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. ASML Stock (NASDAQ: ASML) Update: What to Watch Before Markets Reopen as AI Demand, China Curbs, and High‑NA EUV Shape 2026**
- Source: ts2.tech | 20251227T060922 | Somewhat-Bullish | Relevance: 100%
- This article examines key factors influencing ASML (NASDAQ: ASML) leading into 2026, including strong AI-driven demand, geopolitical challenges like China export limits, and the adoption timing of High-NA EUV technology. It highlights ASML's robust Q3 2025 results and guidance, indicating anticipated strong sales growth for 2025 but a significant decline in China sales for 2026. The piece also details analyst forecasts and various market narratives impacting investor sentiment for the semiconductor giant.

**2. HM Payson & Co. Sells 9,597 Shares of ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251229T120852 | Somewhat-Bullish | Relevance: 100%
- HM Payson & Co. reduced its stake in ASML Holding N.V. by selling 9,597 shares, lowering its total to 98,631 shares valued at approximately $95.48 million. This sale represents an 8.9% reduction and positions ASML as the firm's 23rd largest holding, comprising about 1.4% of its portfolio. While ASML recently surpassed EPS estimates, it missed revenue expectations and has an average price target of $1,171.83 from analysts.

**3. Cantor Fitzgerald Maintains An Overweight Rating On ASML Holding N.V. (ASML)**
- Source: Yahoo Finance UK | 20251228T170923 | Bullish | Relevance: 100%
- Cantor Fitzgerald reiterated an Overweight rating on ASML Holding N.V. (ASML), increasing its price target from €1,150 to €1,300. The firm cited strong demand for semiconductor technology driven by AI deployment and expects continued exposure to AI-related semiconductor names through 2026. This comes despite reports of Chinese semiconductor producers modernizing older ASML equipment amidst export restrictions and a projected sharp drop in ASML's China revenues for 2025.

**4. Valicenti Advisory Services Inc. Buys Shares of 2,705 ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251228T120923 | Bullish | Relevance: 100%
- Valicenti Advisory Services Inc. has acquired 2,705 shares of ASML Holding N.V. in the third quarter, a new position valued at approximately $2.62 million. ASML, traded under the NASDAQ:ASML ticker, continues to demonstrate strong financial performance with a healthy return on equity and net margin, and has recently increased its quarterly dividend. The company maintains a "Moderate Buy" consensus analyst rating and a target price of $1,171.83.

**5. ASML Holding N.V. $ASML Shares Acquired by Carnegie Investment Counsel**
- Source: MarketBeat | 20251228T090923 | Bullish | Relevance: 100%
- Carnegie Investment Counsel significantly increased its stake in ASML Holding N.V. during Q3, now holding 4,892 shares valued at $4.736 million. This move aligns with a broader positive sentiment from Wall Street analysts, who have given ASML a "Moderate Buy" rating with a target price of $1,171.83. The semiconductor giant also reported strong earnings, beating EPS estimates, and raised its quarterly dividend, signaling continued financial health.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | B of A Securiti | $1331 | $1092 | +22% |
| 2025-12-01 | JP Morgan | $1275 | $1175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | B of A Securiti | main | Buy |
| 2025-12-01 | JP Morgan | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 8.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 1.5% (+170.0%)
- Fisher Asset Managem: 1.1% (+2.5%)
- Capital World Invest: 1.1% (-4.1%)
- Capital Internationa: 1.0% (+17.3%)
- State Farm Mutual Au: 0.7% (0.0%)

### Key Risks

1. Premium valuation (P/E 41x, PEG 2.0x) vulnerable to multiple compression.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.01 elevated, pricing in significant growth expectations. Forward P/E 41.1x stretched relative to 5% growth. Quality metrics strong (ROE 54%, ROA 16%, margin 29%). Analyst sentiment positive (2 raises, avg +15%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $413.8B |
| Beta | 1.35 |
| 52W Range | $578.51 - $1141.72 |
| Short Interest | 0.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.01 |
| Forward P/E | 41.1 |
| Current P/E | 43.1 |
| YoY Growth | 4.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -2.1% (minimal 5-day change). Below STRENGTH zone by 6.1pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.4%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.27x) but short-term weakness (below SMA20). MACD histogram bearish (-4.28), momentum weakening. RSI neutral at 51. Volume at 25% of 20MA suggests lack of conviction. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.11% (CS: 21) | Weak |
| RSI_14 | 50.9 | Neutral |
| MACD Histogram | -4.28 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 1.013x | Above |
| vs SMA200 | 1.269x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1065.99
- **Stop Loss:** $1013.49 (4.9% risk)
- **Target:** $1118.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 21
- **Position Value:** $22,385.79
- **Portfolio %:** 22.39%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $7.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.37 | $5.49 | +2.1% |
| 2025Q2 | $5.25 | $5.90 | +12.4% |
| 2025Q1 | $5.79 | $6.00 | +3.7% |
| 2024Q4 | $6.73 | $6.84 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*